Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $1.24 Million - $1.48 Million
-27,500 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $365,700 - $474,225
-7,500 Reduced 21.43%
27,500 $1.43 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $378,975 - $472,350
-7,500 Reduced 17.65%
35,000 $1.94 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $299,600 - $344,900
5,000 Added 13.33%
42,500 $2.69 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $2.07 Million - $2.39 Million
37,500
37,500 $2.39 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hrs Investment Holdings, LLC Portfolio

Follow Hrs Investment Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrs Investment Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hrs Investment Holdings, LLC with notifications on news.